Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
J.B. Hunt Transport Services, Inc. · JBHT · FY2026 Q2 · Calendar Q3 2026
J.B. Hunt's Q2 2026 results show accelerating momentum from Q1, with revenue growing 19% year-over-year and EPS up 45%, beating consensus on both the top and bottom lines. The acceleration was driven by double-digit volume growth across intermodal, dedicated, and truckload segments, amplified by tight truckload capacity that is pushing demand toward J.B. Hunt's intermodal and dedicated solutions. Structural cost removal of over $135 million over the past year is delivering operating leverage. Management expressed confidence in achieving full-year truck sales targets and sustaining margin improvement, while flagging driver labor pressures and fuel headwinds as ongoing challenges. Notably, guidance was not provided this quarter, a shift from the prior quarter's maintained outlook.
Operating across North America, J.B. Hunt Transport Services, Inc. specializes in ground transportation, last-mile delivery, and comprehensive logistics solutions. Its operations are structured into five distinct divisions: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), Final Mile Services (FMS), and Truckload (JBT). The Intermodal (JBI) division facilitates freight movement using multiple transport modes. This segment boasts a substantial asset base, including 104,973 company-owned trailers, a self-maintained fleet of 85,649 chassis, 5,612 company-owned tractors, 582 independent contractor vehicles, and a workforce of 6,943 company drivers. Dedicated Contract Services (DCS) focuses on engineering, implementing, and managing bespoke supply chain strategies for diverse transportation requirements.…
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Jul 16, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 16, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 16, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 16, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 16, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 16, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 16, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 16, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 16, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 13, 2026 |
| Bernstein | Outperform | Market Perform | Upgrade | Jul 10, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Jul 6, 2026 |
| Benchmark | Buy | Buy | Maintain | Jun 26, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 5, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 16, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 11, 2025 |
| Loop Capital | Hold | Hold | Maintain | Oct 17, 2024 |
| Argus Research | Buy | Buy | Maintain | Apr 20, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 19, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jan 19, 2023 |
| Keybanc | Overweight | Downgrade | Sep 30, 2022 | |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 5, 2022 |
| Vertical Research | Hold | Buy | Downgrade | Oct 11, 2021 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 16, 2019 |
| Bank of America | Neutral | Buy | Downgrade | May 28, 2019 |
| Argus | Hold | Buy | Downgrade | Apr 17, 2019 |
| Buckingham Research | Buy | Buy | Maintain | Apr 2, 2019 |
| Buckingham | Buy | Buy | Maintain | Apr 2, 2019 |
| BB&T Capital | Buy | Hold | Upgrade | Jan 25, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Longbow Research | Buy | Neutral | Upgrade | Jul 9, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jun 10, 2015 |
| Nomura | Buy | Buy | Maintain | Apr 14, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Apr 14, 2015 |
| Wunderlich Securities | Buy | Hold | Upgrade | Feb 19, 2014 |
| Wunderlich | Buy | Hold | Upgrade | Feb 19, 2014 |
| Avondale Partners | Market Outperform | Market Perform | Upgrade | Feb 27, 2013 |
| Jefferies | Hold | Hold | Maintain | Jan 25, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Jan 25, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 12, 2012 |
Upside is calculated against the persisted current price $269.21. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $291 | $293.83 | +8.1% | Jul 16, 2026 |
| Truist Financial | Lucas Servera | $295 | $293.6 | +9.6% | Jul 16, 2026 |
| Goldman Sachs | Analyst unavailable | $261 | $276.28 | -3.0% | Jul 16, 2026 |
| Stephens | Analyst unavailable | $370 | $276.28 | +37.4% | Jul 16, 2026 |
| Susquehanna | Analyst unavailable | $345 | $276.28 | +28.2% | Jul 16, 2026 |
| Robert W. Baird | Analyst unavailable | $320 | $276.28 | +18.9% | Jul 16, 2026 |
| Wells Fargo | Analyst unavailable | $335 | $276.28 | +24.4% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $300 | $276.28 | +11.4% | Jul 16, 2026 |
| Raymond James | Analyst unavailable | $315 | $276.28 | +17.0% | Jul 16, 2026 |
| Susquehanna | Analyst unavailable | $326 | $281.36 | +21.1% | Jul 14, 2026 |
| UBS | Analyst unavailable | $286 | $284.66 | +6.2% | Jul 13, 2026 |
| Raymond James | Analyst unavailable | $299 | $284.61 | +11.1% | Jul 13, 2026 |
| Stifel Nicolaus | Bruce Chan | $261 | $279.96 | -3.0% | Jul 13, 2026 |
| Bernstein | Analyst unavailable | $329 | $282.61 | +22.2% | Jul 9, 2026 |
| Goldman Sachs | Analyst unavailable | $239 | $276.45 | -11.2% | Jul 8, 2026 |
| Morgan Stanley | Ravi Shanker | $200 | $285.83 | -25.7% | Jul 6, 2026 |
| Barclays | Brandon Oglenski | $270 | $269.06 | +0.3% | Jun 25, 2026 |
| Robert W. Baird | Daniel Moore | $290 | $279.82 | +7.7% | Jun 17, 2026 |
| BMO Capital | Analyst unavailable | $320 | $287.01 | +18.9% | Jun 5, 2026 |
| Wells Fargo | Christian Wetherbee | $310 | $283.31 | +15.2% | Jun 5, 2026 |
| Evercore ISI | Jonathan Chappell | $248 | $241.93 | -7.9% | May 11, 2026 |
| Argus Research | John Eade | $285 | $247.68 | +5.9% | Apr 20, 2026 |
| Robert W. Baird | Daniel Moore | $236 | $238.32 | -12.3% | Apr 17, 2026 |
| UBS | Thomas Wadewitz | $221 | $236.08 | -17.9% | Apr 16, 2026 |
| Morgan Stanley | Ravi Shanker | $180 | $236.25 | -33.1% | Apr 16, 2026 |
| Truist Financial | Analyst unavailable | $230 | $236.89 | -14.6% | Apr 16, 2026 |
| BMO Capital | Analyst unavailable | $250 | $224.17 | -7.1% | Apr 16, 2026 |
| Wells Fargo | Christian Wetherbee | $250 | $224.17 | -7.1% | Apr 16, 2026 |
| Barclays | Analyst unavailable | $235 | $224.17 | -12.7% | Apr 16, 2026 |
| Raymond James | Analyst unavailable | $240 | $229.61 | -10.9% | Apr 15, 2026 |
| Evercore ISI | Jonathan Chappell | $232 | $206.18 | -13.8% | Mar 26, 2026 |
| BMO Capital | Fadi Chamoun | $245 | $223.38 | -9.0% | Feb 19, 2026 |
| Stifel Nicolaus | Analyst unavailable | $201 | $202.78 | -25.3% | Jan 16, 2026 |
| UBS | Analyst unavailable | $196 | $206.52 | -27.2% | Jan 16, 2026 |
| Evercore ISI | Jonathan Chappell | $222 | $206.52 | -17.5% | Jan 16, 2026 |
| Truist Financial | Analyst unavailable | $205 | $207.19 | -23.9% | Jan 15, 2026 |
| Stifel Nicolaus | Analyst unavailable | $189 | $204.77 | -29.8% | Jan 14, 2026 |
| Evercore ISI | Analyst unavailable | $223 | $206.33 | -17.2% | Jan 12, 2026 |
| Bernstein | Analyst unavailable | $195 | $205.42 | -27.6% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $214 | $205.42 | -20.5% | Jan 8, 2026 |
| Vertical Research | Jeffrey Kauffman | $200 | $204.39 | -25.7% | Jan 8, 2026 |
| Goldman Sachs | Jordan Alliger | $187 | $203.82 | -30.5% | Jan 8, 2026 |
| Susquehanna | Analyst unavailable | $240 | $203.82 | -10.9% | Jan 8, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $202.02 | -18.3% | Jan 6, 2026 |
| Deutsche Bank | Richa Harnain | $227 | $198.18 | -15.7% | Dec 11, 2025 |
| Robert W. Baird | Analyst unavailable | $173 | $164.89 | -35.7% | Oct 17, 2025 |
| Truist Financial | Lucas Servera | $155 | $164.46 | -42.4% | Oct 16, 2025 |
| Stephens | Daniel Imbro | $180 | $165.04 | -33.1% | Oct 16, 2025 |
| Barclays | Analyst unavailable | $150 | $138.83 | -44.3% | Oct 16, 2025 |
| Morgan Stanley | Analyst unavailable | $150 | $138.83 | -44.3% | Oct 16, 2025 |
| UBS | Thomas Wadewitz | $174 | $138.83 | -35.4% | Oct 16, 2025 |
| Stifel Nicolaus | Q3 EPS | $147 | $138.83 | -45.4% | Oct 16, 2025 |
| BMO Capital | Analyst unavailable | $180 | $138.83 | -33.1% | Oct 16, 2025 |
| Bernstein | Analyst unavailable | $172 | $138.83 | -36.1% | Oct 16, 2025 |
| Wells Fargo | Christian Wetherbee | $170 | $138.83 | -36.9% | Oct 16, 2025 |
| Raymond James | Analyst unavailable | $175 | $138.12 | -35.0% | Oct 14, 2025 |
| Bernstein | David Vernon | $158 | $146.55 | -41.3% | Oct 9, 2025 |
| Morgan Stanley | Ravi Shanker | $145 | $137.95 | -46.1% | Oct 6, 2025 |
| Stifel Nicolaus | Analyst unavailable | $140 | $134.2 | -48.0% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $135 | $132.68 | -49.9% | Oct 2, 2025 |
| Evercore ISI | Analyst unavailable | $155 | $134.8 | -42.4% | Sep 30, 2025 |
| UBS | Thomas Wadewitz | $157 | $143.73 | -41.7% | Sep 5, 2025 |
| Goldman Sachs | Jordan Alliger | $164 | $152.54 | -39.1% | Jul 8, 2025 |
| Susquehanna | Bascome Majors | $140 | $124.73 | -48.0% | Apr 16, 2025 |
| Stifel Nicolaus | Bruce Chan | $150 | $124.73 | -44.3% | Apr 16, 2025 |
| Stephens | Daniel Imbro | $165 | $124.73 | -38.7% | Apr 16, 2025 |
| Bernstein | David Vernon | $148 | $124.73 | -45.0% | Apr 16, 2025 |
| Susquehanna | Analyst unavailable | $165 | $151.39 | -38.7% | Mar 26, 2025 |
| Raymond James | Patrick Tyler Brown | $190 | $176.48 | -29.4% | Jan 21, 2025 |
| Susquehanna | Bascome Majors | $200 | $175.1 | -25.7% | Jan 3, 2025 |
| CFRA | Emily Nasseff Mitsch | $151 | $180.15 | -43.9% | Oct 16, 2024 |
| Stifel Nicolaus | Bruce Chan | $167 | $174.65 | -38.0% | Oct 16, 2024 |
| Goldman Sachs | Jordan Alliger | $194 | $174.65 | -27.9% | Oct 16, 2024 |
| Bernstein | David Vernon | $184 | $170.72 | -31.7% | Oct 14, 2024 |
| Evercore ISI | Jonathan Chappell | $183 | $168.14 | -32.0% | Oct 3, 2024 |
| Susquehanna | Bascome Majors | $160 | $171.74 | -40.6% | Sep 26, 2024 |
| BMO Capital | Fadi Chamoun | $195 | $170.19 | -27.6% | Sep 24, 2024 |
| Loop Capital Markets | Rick Paterson | $173 | $161.68 | -35.7% | Jul 18, 2024 |
| CFRA | Arun Sundaram | $174 | $163.9 | -35.4% | Jul 17, 2024 |
| Susquehanna | Bascome Majors | $155 | $176 | -42.4% | Jul 17, 2024 |
| Barclays | Brandon Oglenski | $160 | $176 | -40.6% | Jul 17, 2024 |
| Wells Fargo | Christian Wetherbee | $185 | $174.99 | -31.3% | Jul 16, 2024 |
| Evercore ISI | Jonathan Chappell | $191 | $157.97 | -29.1% | Jun 25, 2024 |
| Barclays | Brandon Oglenski | $170 | $157.62 | -36.9% | May 28, 2024 |
| BMO Capital | Fadi Chamoun | $200 | $168.13 | -25.7% | Apr 17, 2024 |
| Stephens | Justin Long | $192 | $182.99 | -28.7% | Apr 17, 2024 |
| UBS | Thomas Wadewitz | $211 | $182.99 | -21.6% | Apr 17, 2024 |
| Wolfe Research | Scott Group | $200 | $188.19 | -25.7% | Apr 11, 2024 |
| Barclays | Brandon Oglenski | $200 | $199.25 | -25.7% | Apr 1, 2024 |
| UBS | Thomas Wadewitz | $234 | $207.58 | -13.1% | Jan 22, 2024 |
| Loop Capital Markets | Fadi Chamoun | $220 | $190.98 | -18.3% | Dec 11, 2023 |
| Loop Capital Markets | Fadi Chamoun | $200 | $180.74 | -25.7% | Oct 18, 2023 |
| Wells Fargo | Allison Poliniak Cusic | $200 | $187.96 | -25.7% | Jul 18, 2023 |
| Cowen & Co. | Jason Seidl | $193 | $172.42 | -28.3% | Jul 20, 2022 |
| Stifel Nicolaus | Bruce Chan | $184 | $172.63 | -31.7% | May 13, 2022 |
| Morgan Stanley | Analyst unavailable | $170 | $173.77 | -36.9% | Apr 19, 2022 |
| Raymond James | Patrick Brown | $210 | $171.45 | -22.0% | Apr 19, 2022 |
| Wells Fargo | Analyst unavailable | $208 | $173.61 | -22.7% | Apr 19, 2022 |
| BMO Capital | Analyst unavailable | $190 | $174.4 | -29.4% | Apr 19, 2022 |
| Raymond James | Patrick Brown | $205 | $170.88 | -23.9% | Apr 19, 2022 |
| Deutsche Bank | Amit Mehrotra | $230 | $168.23 | -14.6% | Apr 12, 2022 |
| KeyBanc | Todd Fowler | $220 | $170.7 | -18.3% | Apr 11, 2022 |
| J.P. Morgan | Brian Ossenbeck | $187 | $173.18 | -30.5% | Apr 8, 2022 |
| Bank of America Securities | Ken Hoexter | $195 | $173.18 | -27.6% | Apr 8, 2022 |
| Barclays | Brandon Oglenski | $225 | $172.59 | -16.4% | Apr 7, 2022 |
| Robert W. Baird | Garrett Holland | $215 | $173.08 | -20.1% | Apr 5, 2022 |
| Wolfe Research | Scott Group | $220 | $173.08 | -18.3% | Apr 5, 2022 |
| Vertical Research | Jeff Kauffman | $225 | $202.72 | -16.4% | Mar 2, 2022 |
| Deutsche Bank | Amit Mehrotra | $210 | $200 | -22.0% | Jan 20, 2022 |
| UBS | Thomas Wadewitz | $206 | $200.24 | -23.5% | Jan 19, 2022 |
| BMO Capital | Fadi Chamoun | $210 | $200.24 | -22.0% | Jan 19, 2022 |
| KeyBanc | Todd Fowler | $230 | $200.08 | -14.6% | Jan 18, 2022 |
| Citigroup | Christian Wetherbee | $230 | $202.38 | -14.6% | Jan 12, 2022 |
| Evercore ISI | Jonathan Chappell | $221 | $198.64 | -17.9% | Jan 11, 2022 |
| Raymond James | Patrick Brown | $215 | $199.7 | -20.1% | Jan 7, 2022 |
| Morgan Stanley | Ravi Shanker | $165 | $188.37 | -38.7% | Oct 18, 2021 |
| Argus Research | John Eade | $210 | $188.37 | -22.0% | Oct 18, 2021 |
| Stifel Nicolaus | J. Bruce Chan | $172 | $163.46 | -36.1% | Jul 20, 2021 |
| Loop Capital Markets | Rick Paterson | $175 | $165.75 | -35.0% | Apr 19, 2021 |
Track every rating change on JBHT the moment it posts. Free to start.
Start freeFollow JBHT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeRevenue growth accelerated from 5% in Q1 to 19% in Q2 year-over-year. EPS growth jumped from 27% in Q1 to 45% in Q2 year-over-year. Structural cost removal reached $135 million over the past year, up from over $30 million eliminated in Q1 alone. Intermodal container utilization reached approximately 90% with about 20% excess capacity available. Bullish score increased from 70 in Q1 to 78 in Q2. Guidance sentiment shifted from 'maintained' in Q1 to 'not provided' in Q2.
Q1 2026 guidance sentiment was 'maintained'; Q2 2026 guidance was 'not provided' on the call. Capex outlook remains 'stable' from the prior quarter. DCS truck sales target moved to 1,000-1,200 annually, up from 800-1,000 new trucks in 2026 stated in Q1. Cost-to-serve program has removed over $135 million in the past year, tracking toward the $100 million multi-year target disclosed in Q1.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.